Advertisement

Topics

Technical Reports on Biotech Equities -- ImmunoGen, Incyte, Infinity Pharma, and Insmed

06:20 EST 9 Nov 2017 | BioMedReports - Blog

http://dailystocktracker.com/register/

ImmunoGen

On Wednesday, shares in Waltham, Massachusettsheadquartered ImmunoGen Inc. climbed 0.90%, ending the day at $5.59. The stock recorded a trading volume

Read more...

Original Article: Technical Reports on Biotech Equities -- ImmunoGen, Incyte, Infinity Pharma, and Insmed

NEXT ARTICLE

More From BioPortfolio on "Technical Reports on Biotech Equities -- ImmunoGen, Incyte, Infinity Pharma, and Insmed"

Advertisement
Quick Search
Advertisement
Advertisement